vaccines
What You Need To Know About Takeda’s Dengue Vaccine
Derek Wallace, global dengue program medical director of Takeda Pharmaceutical Company, on the company's plans for dengue and Zika vaccines.
Yellow Fever Vaccine Effective Even At Lower Dose
Lowering the dose of the yellow fever vaccine could help extend population coverage even if reduces the vaccine's efficacy, study says.
Using The Common Cold To Tackle HIV
Scientists have used the common cold virus and a DNA-based vaccine to stimulate protection against HIV in the gut and bodily cavities of mice.
7 Must-Read Stories In October 2016
Sanofi Pasteur's dengue vaccine, low-protein diets and a ‘light-stopping’ experiment were popular in October.
Great Hesitation In Adopting Dengue Vaccine
Dengxavia, the world's first approved dengue vaccine, has been rolled out in parts of Asia and South America—but doubts over its efficacy and potential for causing side effects remain.
Takeda To Develop Zika Vaccine With $19.8m BARDA Funding
The US$19.8 million initial funding will cover the development of a Zika vaccine through to a Phase I clinical trial.
A Step Closer To The World’s First Alzheimer’s Vaccine
Researchers in the US and Australia have developed a vaccine formulation that targets the two hallmark proteins of Alzheimer's disease.
Vaccine Helps Immune System ‘Remember’ Cancer Threats
When activated, a special type of modified cell called aAVC promotes the maturation of dendritic cells, the gatekeepers of immune memory.
Astellas, UTokyo To Collaborate On Cholera Vaccine
The partnership will develop a rice-based oral vaccine against cholera and E. coli-related diarrheal diseases.
